New injection triggers fat cell self-destruction to combat obesity
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
An experimental injection called CBL-514 has shown promise in phase 2 clinical trials by triggering apoptosis in fat cells, significantly reducing deep abdominal visceral and subcutaneous fat. Highlighted at the European Association for the Study of Diabetes annual meeting in Milan, the treatment could combat obesity and potentially prevent weight regain after stopping GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound, though the regain prevention has only been shown in animals so far.
Continue in the app — vote & join in ➔Source: ScienceDaily · via ahirlevel.hu